AI Article Synopsis

  • Melanoma is a severe cancer with low survival rates and few treatment options; this study explores the effectiveness of 3-O-prenyl glycyrrhetinic acid (NPC-402) derived from a medicinal plant against aggressive melanoma cells.
  • NPC-402 was shown to induce cell death through mechanisms involving oxidative stress, apoptosis, and autophagy, which were linked to endoplasmic reticulum stress and specific signaling pathways.
  • In mouse models, NPC-402 significantly reduced tumor growth and angiogenesis without major toxicity, suggesting it may be a promising candidate for melanoma treatment.

Article Abstract

Melanoma is an aggressive form of cancer with poor prognosis and survival rates and limited therapeutic options. Here, we report the anti-melanoma effect of 3-O-prenyl glycyrrhetinic acid (NPC-402), a derivative of glycyrrhtinic acid, from a reputed medicinal plant against B16F10 cells. We studied the cytotoxic effect of NPC-402 on melanoma cells and investigated the role of mitogen-activated protein (MAP) kinase, AKT axis, and endoplasmic reticulum (ER) stress/unfolded protein response (UPR)-mediated autophagy as the involved signaling cascade by studying specific marker proteins. In this study, 4-phenylbutyric acid (4PBA, a chemical chaperone) and small interference RNA (siRNA) knockdown of C/EBP Homologous Protein (CHOP)/growth arrest- and DNA damage-inducible gene 153(GAD153) blocked NPC-402-mediated autophagy induction, thus confirming the role of ER stress and autophagy in melanoma cell death. NPC-402 induced oxidative stress and apoptosis in melanoma cells, which were effectively mitigated by treatment with N-acetylcysteine (NAC). studies showed that intraperitoneal (i.p.) injection of NPC-402 at 10 mg/kg (5 days in 1 week) significantly retarded angiogenesis in the Matrigel plug assay and reduced the tumor size and tumor weight without causing any significant toxic manifestation in C57BL/6J mice. We conclude that NPC-402 has a high potential to be developed as a chemotherapeutic drug against melanoma.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380594PMC
http://dx.doi.org/10.3389/fonc.2022.890299DOI Listing

Publication Analysis

Top Keywords

anti-melanoma 3-o-prenyl
8
3-o-prenyl glycyrrhetinic
8
glycyrrhetinic acid
8
b16f10 cells
8
endoplasmic reticulum
8
melanoma cells
8
melanoma
5
npc-402
5
synthesis anti-melanoma
4
acid
4

Similar Publications

Article Synopsis
  • Melanoma is a severe cancer with low survival rates and few treatment options; this study explores the effectiveness of 3-O-prenyl glycyrrhetinic acid (NPC-402) derived from a medicinal plant against aggressive melanoma cells.
  • NPC-402 was shown to induce cell death through mechanisms involving oxidative stress, apoptosis, and autophagy, which were linked to endoplasmic reticulum stress and specific signaling pathways.
  • In mouse models, NPC-402 significantly reduced tumor growth and angiogenesis without major toxicity, suggesting it may be a promising candidate for melanoma treatment.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!